These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 9744794)

  • 21. Tau-based treatment strategies in neurodegenerative diseases.
    Schneider A; Mandelkow E
    Neurotherapeutics; 2008 Jul; 5(3):443-57. PubMed ID: 18625456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
    Botez G; Probst A; Ipsen S; Tolnay M
    Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.
    Bussière T; Hof PR; Mailliot C; Brown CD; Caillet-Boudin ML; Perl DP; Buée L; Delacourte A
    Acta Neuropathol; 1999 Mar; 97(3):221-30. PubMed ID: 10090668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
    Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
    Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
    J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exon 3 insert of tau protein in neurodegenerative diseases.
    Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
    Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer's disease.
    Camacho J; Rábano A; Marazuela P; Bonaterra-Pastra A; Serna G; Moliné T; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M
    Brain Pathol; 2022 Jan; 32(1):e13016. PubMed ID: 34514662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential incorporation of tau isoforms in Alzheimer's disease.
    Espinoza M; de Silva R; Dickson DW; Davies P
    J Alzheimers Dis; 2008 May; 14(1):1-16. PubMed ID: 18525123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly of filamentous tau aggregates in human neuronal cells.
    Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
    J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tau protein abnormality and dementia: the mechanisms of neurodegeneration].
    Tanaka T; Takeda M
    No To Shinkei; 2002 Sep; 54(9):777-87. PubMed ID: 12428364
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration.
    Feany MB; Mattiace LA; Dickson DW
    J Neuropathol Exp Neurol; 1996 Jan; 55(1):53-67. PubMed ID: 8558172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
    Goedert M; Spillantini MG
    Biochim Biophys Acta; 2000 Jul; 1502(1):110-21. PubMed ID: 10899436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Blanco R; Carmona M; Puig B
    Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
    Delacourte A
    Biomed Pharmacother; 1994; 48(7):287-95. PubMed ID: 7858159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characterization of glial fibrillary tangles in progressive supranuclear palsy and Alzheimer's disease].
    Nishimura M
    No To Shinkei; 1996 Oct; 48(10):895-903. PubMed ID: 8921528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.